
Inhibiting beta cell infection from enteroviruses may prevent the development of type 1 diabetes.

Inhibiting beta cell infection from enteroviruses may prevent the development of type 1 diabetes.

Some diabetes drugs may impact bone metabolism and strength.

The National Diabetes Statistics Report found that 1 in 4 patients are unaware they have diabetes.

The FDA has granted tentative approval to Merck's Lusduna Nexvue (insulin glargine injection) 100 units/mL. The drug is a follow-on biologic basal insulin for patients with type 2 diabetes and is administered through a pre-filled dosing device, according to a press release.

Lusduna Nexvue insulin glargine injection is a follow-on biologic for patients with type 2 diabetes.

Sanofi lawsuit delays emergence of follow-on biologic of insulin glargine injection for type 2 diabetes.

This article contains a great snapshot into U-500 education to further your knowledge and promote patient safety.

The National Diabetes Statistics Report, released approximately every 2 years, provides information on diabetes prevalence and incidence, prediabetes, risk factors for complications, acute and long-term complications, mortality, and costs in the United States.

Type 2 diabetes can alter the oral microbiome and lead to inflammation.

Web-based weight loss intervention shows promise addressing obesity in patients with type 2 diabetes.

An asthma drug may potentially be useful in treating type 2 diabetes, according to a recently-published study.

The Alexa Diabetes Challenge harnesses voice-activated technology to improve diabetes outcomes.

Top news of the day from across the health care landscape.

The number of patients who have from diabetes is expected to almost double from 285 million to 438 million people by 2030 due to obesity trends.

SmartMat offers early protection against nontraumatic plantar foot ulcers foot ulcers before presentation.

Amlexanox may alter genes that improve blood glucose control in patients with type 2 diabetes.

Top news of the day from across the health care landscape.

Patients with obstructive sleep apnea and type 2 diabetes have an increased risk of retinopathy.

Children diagnosed with diabetic ketoacidosis and type 1 diabetes may have higher HbA1C levels.

Pharmacists’ roles are expanding from traditional retail settings, allowing them to be more involved in patient care than ever before.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Eradicating hepatitis C virus with antiviral drugs found to improve comorbid conditions.

Diabetes' propensity to cause metabolic derangement is directly responsible for a looming epidemic of diabetic kidney disease (DKD). And left unchecked, DKD can progress to end-stage kidney disease (ESKD).

How can we reduce the burden of type 1 diabetes? Automated insulin delivery systems could be the answer.